nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00562	0.0473	CcSEcCtD
Fesoterodine—Angina pectoris—Metformin—polycystic ovary syndrome	0.00518	0.0436	CcSEcCtD
Fesoterodine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0051	0.0429	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00494	0.0416	CcSEcCtD
Fesoterodine—Infestation NOS—Metformin—polycystic ovary syndrome	0.00474	0.0399	CcSEcCtD
Fesoterodine—Infestation—Metformin—polycystic ovary syndrome	0.00474	0.0399	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00448	0.0378	CcSEcCtD
Fesoterodine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00419	0.0353	CcSEcCtD
Fesoterodine—Eye disorder—Metformin—polycystic ovary syndrome	0.00398	0.0335	CcSEcCtD
Fesoterodine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00395	0.0333	CcSEcCtD
Fesoterodine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00384	0.0323	CcSEcCtD
Fesoterodine—Flatulence—Metformin—polycystic ovary syndrome	0.00365	0.0307	CcSEcCtD
Fesoterodine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00363	0.0305	CcSEcCtD
Fesoterodine—Vision blurred—Metformin—polycystic ovary syndrome	0.00349	0.0294	CcSEcCtD
Fesoterodine—Palpitations—Metformin—polycystic ovary syndrome	0.00327	0.0276	CcSEcCtD
Fesoterodine—Chest pain—Metformin—polycystic ovary syndrome	0.00315	0.0266	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00313	0.0264	CcSEcCtD
Fesoterodine—Infection—Metformin—polycystic ovary syndrome	0.003	0.0253	CcSEcCtD
Fesoterodine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00297	0.025	CcSEcCtD
Fesoterodine—Skin disorder—Metformin—polycystic ovary syndrome	0.00294	0.0247	CcSEcCtD
Fesoterodine—Somnolence—Metformin—polycystic ovary syndrome	0.00269	0.0226	CcSEcCtD
Fesoterodine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00266	0.0224	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00261	0.022	CcSEcCtD
Fesoterodine—Fatigue—Metformin—polycystic ovary syndrome	0.00261	0.0219	CcSEcCtD
Fesoterodine—Constipation—Metformin—polycystic ovary syndrome	0.00259	0.0218	CcSEcCtD
Fesoterodine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00249	0.021	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00247	0.0208	CcSEcCtD
Fesoterodine—Urticaria—Metformin—polycystic ovary syndrome	0.0024	0.0202	CcSEcCtD
Fesoterodine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00239	0.0201	CcSEcCtD
Fesoterodine—Asthenia—Metformin—polycystic ovary syndrome	0.00217	0.0183	CcSEcCtD
Fesoterodine—Pruritus—Metformin—polycystic ovary syndrome	0.00214	0.018	CcSEcCtD
Fesoterodine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00207	0.0174	CcSEcCtD
Fesoterodine—Dizziness—Metformin—polycystic ovary syndrome	0.002	0.0168	CcSEcCtD
Fesoterodine—Rash—Metformin—polycystic ovary syndrome	0.00191	0.0161	CcSEcCtD
Fesoterodine—Dermatitis—Metformin—polycystic ovary syndrome	0.00191	0.016	CcSEcCtD
Fesoterodine—Headache—Metformin—polycystic ovary syndrome	0.00189	0.0159	CcSEcCtD
Fesoterodine—Nausea—Metformin—polycystic ovary syndrome	0.0018	0.0151	CcSEcCtD
Fesoterodine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000162	0.000184	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000162	0.000184	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000162	0.000184	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000162	0.000184	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000162	0.000184	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000162	0.000183	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000161	0.000183	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000161	0.000182	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000161	0.000182	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00016	0.000182	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.00016	0.000181	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.00016	0.000181	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000159	0.00018	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000158	0.00018	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000158	0.000179	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000157	0.000179	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000157	0.000178	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000155	0.000176	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000155	0.000176	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000155	0.000175	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000153	0.000174	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000152	0.000173	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000152	0.000172	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000151	0.000172	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000151	0.000172	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000151	0.000172	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000151	0.000171	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000151	0.000171	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000151	0.000171	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000151	0.000171	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000151	0.000171	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00015	0.000171	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00015	0.00017	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00015	0.00017	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000149	0.000169	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000149	0.000169	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000149	0.000169	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000148	0.000168	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000148	0.000168	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PRL—polycystic ovary syndrome	0.000148	0.000168	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000147	0.000167	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000144	0.000163	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000143	0.000163	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000143	0.000162	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000142	0.000162	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000142	0.000161	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000142	0.000161	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000142	0.000161	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000141	0.00016	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000141	0.00016	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000141	0.00016	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000139	0.000158	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000139	0.000158	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000139	0.000157	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000138	0.000156	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000138	0.000156	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000137	0.000156	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000137	0.000155	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000136	0.000154	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000135	0.000153	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000133	0.000151	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000133	0.000151	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000131	0.000149	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000131	0.000149	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00013	0.000148	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000128	0.000146	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000128	0.000146	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000126	0.000144	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000126	0.000143	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000125	0.000142	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000125	0.000142	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000125	0.000142	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000124	0.000141	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000124	0.000141	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000124	0.000141	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000124	0.000141	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000124	0.00014	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000123	0.00014	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000123	0.000139	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000123	0.000139	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000122	0.000138	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000122	0.000138	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000121	0.000137	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000119	0.000135	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000117	0.000133	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000117	0.000133	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000117	0.000133	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000115	0.000131	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000115	0.00013	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000115	0.00013	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000114	0.00013	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000114	0.00013	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000114	0.00013	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000113	0.000128	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000113	0.000128	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000111	0.000126	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00011	0.000125	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00011	0.000125	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000109	0.000124	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000109	0.000124	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000109	0.000124	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000109	0.000124	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000108	0.000122	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000108	0.000122	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000107	0.000121	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000107	0.000121	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000106	0.000121	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000106	0.00012	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000106	0.00012	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000105	0.000119	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000105	0.000119	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000105	0.000119	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000104	0.000119	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000104	0.000118	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000104	0.000118	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000103	0.000116	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—LEP—polycystic ovary syndrome	0.000102	0.000116	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000101	0.000115	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000101	0.000114	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000101	0.000114	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000101	0.000114	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.0001	0.000114	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.0001	0.000114	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.0001	0.000113	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	9.99e-05	0.000113	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	9.99e-05	0.000113	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	9.96e-05	0.000113	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	9.96e-05	0.000113	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	9.89e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	9.87e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—LEP—polycystic ovary syndrome	9.79e-05	0.000111	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	9.67e-05	0.00011	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.63e-05	0.000109	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.6e-05	0.000109	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	9.57e-05	0.000109	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	9.55e-05	0.000108	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.51e-05	0.000108	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.48e-05	0.000108	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	9.47e-05	0.000107	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.45e-05	0.000107	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	9.42e-05	0.000107	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.36e-05	0.000106	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.3e-05	0.000105	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IRS1—polycystic ovary syndrome	9.12e-05	0.000103	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	9.01e-05	0.000102	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	8.87e-05	0.000101	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.87e-05	0.000101	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	8.83e-05	0.0001	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.79e-05	9.98e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	8.78e-05	9.96e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	8.77e-05	9.95e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	8.73e-05	9.91e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	8.73e-05	9.91e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	8.68e-05	9.85e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	8.45e-05	9.59e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	8.44e-05	9.58e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	8.41e-05	9.54e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.38e-05	9.51e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	8.36e-05	9.49e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.35e-05	9.48e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.27e-05	9.38e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	8.22e-05	9.33e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	8.2e-05	9.3e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.15e-05	9.25e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	8.12e-05	9.21e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	8.09e-05	9.18e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.09e-05	9.18e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	8.08e-05	9.17e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.02e-05	9.1e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.93e-05	8.99e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.9e-05	8.97e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.68e-05	8.72e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	7.68e-05	8.71e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.66e-05	8.69e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	7.47e-05	8.48e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.45e-05	8.46e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	7.16e-05	8.12e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	7.06e-05	8.01e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.05e-05	8e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.04e-05	7.99e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	7.02e-05	7.97e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	7.02e-05	7.97e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—INS—polycystic ovary syndrome	7.02e-05	7.97e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	6.95e-05	7.89e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	6.89e-05	7.82e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	6.87e-05	7.8e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.82e-05	7.74e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	6.8e-05	7.72e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.65e-05	7.55e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.58e-05	7.46e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	6.46e-05	7.33e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.34e-05	7.19e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.32e-05	7.17e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	6.27e-05	7.11e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.24e-05	7.08e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	6.19e-05	7.02e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.15e-05	6.98e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	6.13e-05	6.96e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.07e-05	6.89e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.01e-05	6.82e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.97e-05	6.78e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	5.92e-05	6.72e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	5.9e-05	6.7e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.89e-05	6.69e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	5.89e-05	6.68e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	5.87e-05	6.66e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	5.84e-05	6.63e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	5.81e-05	6.6e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.8e-05	6.58e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.7e-05	6.46e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.69e-05	6.46e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	5.68e-05	6.44e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	5.67e-05	6.44e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.66e-05	6.42e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	5.62e-05	6.38e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	5.62e-05	6.38e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.6e-05	6.36e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.52e-05	6.26e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.41e-05	6.14e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.39e-05	6.12e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.34e-05	6.06e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.28e-05	6e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	5.28e-05	5.99e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.02e-05	5.7e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.88e-05	5.54e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.59e-05	5.21e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.54e-05	5.15e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.48e-05	5.08e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.45e-05	5.05e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.36e-05	4.94e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	4.34e-05	4.93e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.3e-05	4.88e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.28e-05	4.86e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.22e-05	4.79e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.2e-05	4.76e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.1e-05	4.65e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.9e-05	4.43e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	3.82e-05	4.33e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.72e-05	4.22e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.71e-05	4.21e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.7e-05	4.2e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.67e-05	4.17e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	3.65e-05	4.15e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.45e-05	3.92e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.8e-05	3.17e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.76e-05	3.13e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.74e-05	3.11e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	2.57e-05	2.92e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	2.56e-05	2.91e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.54e-05	2.88e-05	CbGpPWpGaD
